XML 28 R14.htm IDEA: XBRL DOCUMENT

Equity Based Compensation	3 Months Ended
Equity Based Compensation	Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]
Equity Based Compensation	Equity Based Compensation Equity compensation expense was $7 million and $6 million for the three months ended March 31, 2025 and 2024, respectively. In the first quarter of 2025, the Company granted 120,011 stock appreciation rights at $193.00 weighted average exercise price per share, 131,836 performance shares and 86,474 restricted stock units to employees. As of March 31, 2025, 1,309,098 share awards at a weighted average strike price per share of $124.25 were vested and exercisable with a remaining weighted average exercise period of 4.5 years. As of March 31, 2025, the total compensation cost of non-vested awards not yet recognized in the financial statements was $86 million. It is estimated that these costs will vest over a weighted average period of 1.0 year.